C-RAD AB ser. B
C-Rad AB: Griffin Health launches its frameless SRS program using C-RAD Catalyst HD with cBrain software
Griffin Health launches its frameless SRS program using C-RAD Catalyst HD
with cBrain software
C-RAD announced today that the Center for Cancer Care at Griffin Hospital
in Derby, CT, in partnership with physicians and physicists from the Yale
University School of Medicine, has launched its frameless SRS program using
C-RAD Catalyst HD in combination with a dedicated software package for
stereotactic treatments - cBrain.
C-RAD launched its latest software release with a new version of its
dedicated module for stereotactic treatments. The clinical benefits of the
new module are highest accuracy, a user friendly and safety driven workflow
as well as a unique routine for quality assurance. Griffin Hospital is the
first center in North America to implement the latest software into their
clinical routine for SRS treatments.
The C-RAD Catalyst HD System at Griffin Hospital is installed at Elekta
Synergy linear accelerators which are equipped with the Agility MLC and the
HexaPod couch top. The cBrain software module is also available for our
customers, that are using Varian linear accelerators.
The section of Radiation Oncology at Griffins Center for Cancer Care is
very excited to have developed this method, Dr. Cardinale, Associate
Professor of Therapeutic Radiology at Yale University School of Medicine
and Medical Director at the Center for Cancer Care, Griffin Hospital said.
This ultra-precise technique of 1 to 5 treatments significantly reduces
the amount of time patients have to come in for treatment and is
potentially amore effective therapy. It is through the efforts of our
great team and staff members that Griffin has become the first center in
North America use the new C-RADCatalyst HDSRT surface imaging module as a
primary monitoring tool during brain radiosurgery.
It is an important milestone: There is a huge interest from our customers
to implement C-RADs cutting-edge technology for SRS treatments -
especially in North America. says Tim Thurn, CEO and President of C-RAD
AB, It was a pleasure to work with the team at Griffin Hospital in the
implementation phase of our most recent software release. We are looking
forward to deploying this module worldwide to make the technology available
to an increasing number of patients.
To learn more about radiation therapy at Griffin Hospital visit their
website or take a video journey through the department presented by Joseph
Cardinale, MD Medical Director of radiation oncology.
SRS (stereotactic radiosurgery) is a modern form of delivering radiation
therapy, where the radiation dose is deposited with highest precision for
tumors or other medical conditions in the brain or central nervous system
(CNS) within one to five treaments. For such treatments the accurate
position of the skull throughout the duration of the treatment is crucial
to achieve clinical outcome. Whereas today in many cases mechanical
restraints are used to fixate the position of the skull, a transition
towards a combination of a mask and a surface tracking system like C-RAD
Catalyst HD System is used, with the advantage of improving patient comfort
and at the same time decrease treatment fractions which makes limited
treatment resources available to more patients.
About Griffin Hospital
Griffin Hospital is a 160-bed acute care community hospital serving more
than 130,000 residents of the Lower Naugatuck Valley Region. Griffin
Hospital also serves as the flagship hospital for Planetree, an
international leader in patient-centered care and has received national
recognition for creating a healthcare facility and an approach to patient
care that is responsive to the needs of patients. Many healthcare
organizations around the world send visitors to Griffin Hospitals
facilities and incorporate its Planetree concepts into their healthcare
models. Griffin Hospital is affiliated with the Yale School of Medicine,
The Frank H. Netter MD School of Medicine at Quinnipiac University, and
accredited by The Joint Commission.
C-RAD develops innovative solutions for use in advanced radiation therapy.
The C-RAD group offers products and solutions for patient positioning,
tumor localization and radiation treatment systems. All product development
is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD
Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala,
Sweden. C-RAD has established two companies for direct sales: C-RAD Inc. in
the US and C-RAD GmbH in Germany. Cyrpa International SPRL, a
Franco-Belgian laser company, is a wholly owned subsidiary whose operations
are integrated. C-RAD AB is listed on NASDAQ Stockholm.
For more information on C-RAD, please visit http://www.c-rad.com
For further information:
Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email email@example.com
* PR 20190215 Treatment SRS consortium ENG